Cytoxic Finished Dosage Formulation @Chemi Pharma Ltd in Malta
Chemi Pharma, subsidiary of Chemi SPA, is a pharmaceutical company that delivers cytotoxic injectable Finished Dosage Formulation complying with international pharmaceutical standards: EMA (Europe), FDA (USA) and PMDA (JP)
Chemi Pharma (Plant start-up foreseen 1Q 2016) is developing a comprehensive portfolio of : “fully in-house developed” generic oncology products: Chemi SPA’s Products are sold worldwide in cooperation with Sales and Marketing team of key global players.
Chemi Pharma will act as well as CDMO offering development and manufacturing services to clients and partners internationally.
CDMO service is characterized by customer oriented approach, allowing a high level of flexibility to fulfill customer’s needs and standards. Tailored development, turnkey package of analytical services, support drug development process will complete the services offered.